LASS6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.160800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.299800E-01
Normal-vs-Stage2
2.125800E-01
Normal-vs-Stage3
9.654800E-01
Normal-vs-Stage4
1.374770E-01
Stage1-vs-Stage2
8.330600E-01
Stage1-vs-Stage3
1.800560E-01
Stage1-vs-Stage4
1.661630E-01
Stage2-vs-Stage3
1.607620E-01
Stage2-vs-Stage4
4.167700E-02
Stage3-vs-Stage4
8.564400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.299600E-01
Normal-vs-AfricanAmerican
1.403230E-01
Normal-vs-Asian
3.361800E-01
Caucasian-vs-AfricanAmerican
6.773600E-01
Caucasian-vs-Asian
5.886200E-01
AfricanAmerican-vs-Asian
4.393800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.034600E-01
Normal-vs-Female
2.494400E-01
Male-vs-Female
4.281000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.713800E-01
Normal-vs-Age(41-60Yrs)
1.133560E-01
Normal-vs-Age(61-80Yrs)
2.808200E-01
Normal-vs-Age(81-100Yrs)
4.582200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.309400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.036800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.839400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.953500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.604300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.752000E-01
Normal-vs-Daily Drinker
3.895600E-01
Normal-vs-Weekly Drinker
3.715000E-01
Normal-vs-Occasional Drinker
9.246400E-02
Normal-vs-Social Drinker
2.002200E-01
Non Drinker-vs-Daily Drinker
4.377800E-01
Non Drinker-vs-Weekly Drinker
6.395200E-01
Non Drinker-vs-Occasional Drinker
8.758600E-03
Non Drinker-vs-Social Drinker
7.660400E-02
Daily Drinker-vs-Weekly Drinker
7.831600E-01
Daily Drinker-vs-Occasional Drinker
7.894000E-02
Daily Drinker-vs-Social Drinker
4.726400E-01
Weekly Drinker-vs-Occasional Drinker
5.311600E-02
Weekly Drinker-vs-Social Drinker
3.214800E-01
Occasional Drinker-vs-Social Drinker
3.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.168390E-01
Normal-vs-Grade 2
5.595600E-02
Normal-vs-Grade 3
5.304000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.950100E-02
Grade 1-vs-Grade 3
2.446400E-02
Grade 1-vs-Grade 4
1.168390E-01
Grade 2-vs-Grade 3
3.173200E-01
Grade 2-vs-Grade 4
5.595600E-02
Grade 3-vs-Grade 4
5.304000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.193400E-01
Normal-vs-NonDiabetic
2.302400E-01
Diabetic-vs-NonDiabetic
8.543200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.914200E-02
Normal-vs-NoPancreatitis
2.440200E-01
Pancreatitis-vs-NoPancreatitis
9.698000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.480600E-01
Normal-vs-N1
2.053800E-01
N0-vs-N1
6.164400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.080550E-01
Normal-vs-TP53-NonMutant
2.105200E-01
TP53-Mutant-vs-TP53-NonMutant
5.168300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
